Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology

Symptoms, Biology, and CIDP Variants

At a Glance

CIDP symptoms happen when the immune system attacks the myelin insulation of peripheral nerves. While Typical CIDP causes symmetric weakness and numbness in the arms and legs, specific variants—like DADS, MADSAM, Pure Motor, and Pure Sensory—affect different nerves in unique patterns.

While the biological “engine” of CIDP is the same—an immune system attack on the myelin insulation of your nerves—the way it feels can vary wildly from person to person. Because your peripheral nerves control different functions and reach different parts of your body, the “location” of the attack determines your specific symptoms [1][2].

The Biology: Why Symptoms Happen

Think of your nerves as a vast electrical grid. Myelin is the protective coating that ensures electricity moves quickly and efficiently to its destination.

  • Motor Nerves carry signals to your muscles to move. When their myelin is damaged, signals arrive late or not at all, causing weakness and muscle fatigue [3].
  • Sensory Nerves carry signals like touch, temperature, and position back to your brain. When their myelin is damaged, the brain receives “static” or “missing data,” leading to numbness, tingling, or a loss of balance (ataxia) [4].

In 2021, the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) updated the “map” for CIDP, distinguishing between Typical CIDP and several Variants [1][5].

Typical CIDP: The Classic Pattern

This is the most common form. It is symmetric, meaning it affects both sides of the body equally [3].

  • Proximal and Distal Weakness: You feel weakness in your “ends” (feet and hands) AND your “core” (shoulders and hips). This might make it hard to both button a shirt and climb stairs [6].
  • Sensory Loss: Numbness and tingling usually follow the same symmetric pattern [3].

The CIDP Variants: Specific Patterns

Not everyone fits the “classic” mold. The 2021 guidelines recognize four main variants based on which nerves are targeted and where [1][7]:

Variant Where it Hits Primary Symptoms
Distal (DADS) Only the hands and feet. Symmetric numbness and weakness starting in the toes/fingers and staying primarily in the lower arms and legs [8].
Multifocal (MADSAM) Individual nerves, one at a time. Asymmetric symptoms. You might have a weak left hand and a numb right foot. It often feels like “patchy” nerve damage [3][8].
Pure Sensory Only the sensory nerves. No muscle weakness. Instead, you experience severe numbness and “sensory ataxia”—a feeling of being unsteady or “drunk” when walking, especially in the dark [4][9].
Pure Motor Only the motor nerves. Progressive muscle weakness without any numbness or tingling [8][10].

Why This Matters for You

The type of CIDP you have isn’t just a label; it helps your medical team predict how the disease might progress and which treatments might work best [1]. For example, the MADSAM variant often shows “conduction blocks” on electrical tests—spots where the nerve signal is completely stopped—which helps doctors confirm the diagnosis [11]. Similarly, Pure Motor CIDP requires careful monitoring because it can sometimes look like other motor-only conditions, but it often responds well to IVIG therapy [10].

Understanding your specific “map” allows you to talk to your doctor about targeted goals, whether that’s regaining the strength to stand (proximal) or the fine motor skills to type (distal) [1].

Common questions in this guide

Why do CIDP symptoms vary so much from person to person?
Symptoms depend on which specific nerves are damaged by the immune system. If motor nerves are affected, you will experience muscle weakness, whereas sensory nerve damage causes numbness, tingling, and balance issues.
What is Typical CIDP?
Typical CIDP is the most common form of the condition. It causes symmetric symptoms, meaning it affects both sides of the body equally, typically causing weakness and numbness in both your core and extremities.
What is the MADSAM variant of CIDP?
MADSAM is a multifocal variant of CIDP where nerves are attacked individually rather than symmetrically. This causes uneven or asymmetrical symptoms, such as having weakness in one hand but numbness in the opposite foot.
How does Pure Sensory CIDP differ from other types?
Pure Sensory CIDP only affects the nerves responsible for feeling, meaning patients do not experience muscle weakness. Instead, symptoms include severe numbness and sensory ataxia, which is a feeling of unsteadiness or balance loss, especially in the dark.
Why is it important to know my specific CIDP variant?
Knowing your exact subtype helps your medical team predict your disease progression and tailor your treatment. For instance, some variants respond better to specific therapies like IVIG or steroids, and may show unique patterns on nerve conduction studies.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my clinical presentation align more with 'Typical CIDP' or one of the recognized variants like MADSAM or Distal CIDP?
  2. 2.Given that I have [pure sensory/pure motor] symptoms, what supportive evidence (like CSF protein or MRI) was used to confirm my diagnosis?
  3. 3.Do my nerve conduction studies show 'conduction block,' and how does that help distinguish my condition from other neuropathies?
  4. 4.Since some variants respond differently to medications, how does my specific classification affect our choice between steroids and IVIG?
  5. 5.If my symptoms are asymmetrical, are we looking for nerve enlargement using ultrasound or MRI to confirm a multifocal pattern?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.

    Van den Bergh PYK, van Doorn PA, Hadden RDM, et al.

    European journal of neurology 2021; (28(11)):3556-3583 doi:10.1111/ene.14959.

    PMID: 34327760
  2. 2

    Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy.

    Stascheit F, Roos A, Schroeter CB, et al.

    Acta neuropathologica 2025; (150(1)):32 doi:10.1007/s00401-025-02936-w.

    PMID: 40971018
  3. 3

    Chronic Inflammatory Demyelinating Polyneuropathy.

    Kuwabara S, Misawa S

    Advances in experimental medicine and biology 2019; (1190()):333-343 doi:10.1007/978-981-32-9636-7_21.

    PMID: 31760654
  4. 4

    Chronic immune sensorimotor polyradiculopathy: Report of a case series.

    Thammongkolchai T, Suhaib O, Termsarasab P, et al.

    Muscle & nerve 2019; (59(6)):658-664 doi:10.1002/mus.26436.

    PMID: 30697760
  5. 5

    Tips in navigating the diagnostic complexities of chronic inflammatory demyelinating polyradiculoneuropathy.

    Lewis RA, van Doorn PA, Sommer C

    Journal of the neurological sciences 2022; (443()):120478 doi:10.1016/j.jns.2022.120478.

    PMID: 36368137
  6. 6

    Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.

    Ikeda S, Koike H, Nishi R, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(9)):988-996 doi:10.1136/jnnp-2019-320741.

    PMID: 31227562
  7. 7

    [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].

    Kuwabara S

    Rinsho shinkeigaku = Clinical neurology 2024; (64(5)):321-325 doi:10.5692/clinicalneurol.cn-001937.

    PMID: 38644208
  8. 8

    Treatment Approaches for Atypical CIDP.

    Menon D, Katzberg HD, Bril V

    Frontiers in neurology 2021; (12()):653734 doi:10.3389/fneur.2021.653734.

    PMID: 33790853
  9. 9

    Chronic immune sensory polyradiculopathy (CISP): First juvenile case description.

    Sotgiu S, Minutolo A, Carta A, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(1)):333-336 doi:10.1007/s10072-020-04588-y.

    PMID: 32651857
  10. 10

    RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE.

    Liberatore G, Manganelli F, Cocito D, et al.

    Journal of the peripheral nervous system : JPNS 2020; doi:10.1111/jns.12378.

    PMID: 32343015
  11. 11

    Defining chronic inflammatory demyelinating polyradiculoneuropathy subtypes.

    Hughes RAC

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(9)):963 doi:10.1136/jnnp-2019-321250.

    PMID: 31227561

This page explains CIDP symptoms and disease variants for educational purposes. Always consult your neurologist to properly diagnose your specific variant and determine the safest, most effective treatment plan.

Get notified when new evidence is published on Chronic inflammatory demyelinating polyneuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.